{"slideshow_credits": null, "snippet": "Alzheimer\u2019s disease is scary, but that\u2019s no reason to waste money on a test that really doesn\u2019t help.", "abstract": "Ezekiel J Emanuel Op-Ed article supports Medicare's decision to only pay for a test that determines whether a person is likely to suffer from Alzheimer's if the patient is part of a randomized, controlled trial; says test is important for research on the disease, but does not yet accurately predict the possibility that someone will get it.", "section_name": "Opinion", "print_page": "9", "document_type": "article", "byline": {"person": [{"lastname": "EMANUEL", "rank": 1, "firstname": "Ezekiel", "role": "reported", "organization": "", "middlename": "J."}], "original": "By EZEKIEL J. EMANUEL", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/11/17/opinion/sunday/alzheimers-anxiety.html", "lead_paragraph": "Alzheimer\u2019s disease is scary, but that\u2019s no reason to waste money on a test that really doesn\u2019t help.", "headline": {"print_headline": "Alzheimer\u2019s Anxiety", "main": "Alzheimer\u2019s Anxiety", "content_kicker": "Contributing Op-Ed Writer", "kicker": "Op-Ed | Ezekiel J. Emanuel"}, "_id": "5287cb0538f0d806fedf3f10", "word_count": "1001", "multimedia": [{"height": 126, "url": "images/2013/10/04/opinion/Emanuel-contributor/contibutors-images-slide-KQ7U-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/10/04/opinion/Emanuel-contributor/contibutors-images-slide-KQ7U-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 600, "url": "images/2013/10/04/opinion/Emanuel-contributor/Emanuel-contributor-articleLarge-v2.jpg", "legacy": {"xlarge": "images/2013/10/04/opinion/Emanuel-contributor/Emanuel-contributor-articleLarge-v2.jpg", "xlargewidth": "600", "xlargeheight": "600"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/10/04/opinion/Emanuel-contributor/Emanuel-contributor-thumbStandard-v2.jpg", "legacy": {"thumbnail": "images/2013/10/04/opinion/Emanuel-contributor/Emanuel-contributor-thumbStandard-v2.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-11-17T00:00:00Z", "source": "The New York Times", "news_desk": "Editorial", "keywords": [{"name": "subject", "value": "Alzheimer's Disease", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Dementia", "is_major": "N", "rank": "2"}, {"name": "subject", "value": "Tests (Medical)", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "Eli Lilly and Company", "is_major": "N", "rank": "4"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Medicare", "is_major": "Y", "rank": "6"}], "blog": [], "subsection_name": "Sunday Review", "type_of_material": "Op-Ed"}